Successful management and withdrawal of conventional medicine in Amavata patient (Seropositive Rheumatoid Arthritis) with an Ayurvedic intervention: A Case Report : Withdrawal of conventional medication by Ayurvedic management in Amavata (rheumatoid arthritis)

Abstract

Amavata (~Rheumatoid arthritis) is the most common condition among chronic inflammatory joint diseases. It occurs due to impairment of Agni (digestive fire), formation of Ama (bio-toxin) and vitiation of Vata Dosha. The produced Ama is carried by the aggravated Vata which gets deposited in the Shleshmasthana (Asthi - sandhi) and produces “Amavata”. The clinical features of Amavata are identical to Rheumatoid arthritis. In Conventional medicines NSAIDs, DMARDs, JAK inhibitors and corticosteroids plays a major role in the treatment of this condition; but they have serious adverse effects and have limitations for long-term therapy. Conventional drugs only provide temporary control to the pain but the possibility of further damage to joints remains the same because the root cause of the disorder remains unattended. This issue increases the urge to research the new possibilities of drugs that have predictable efficacy and a low toxic profile in this debilitating disorder. Ayurveda focuses on treating the root cause and breakdown of pathogenesis with the help of modalities like Langhana, Swedana, and use of drugs having Tikta, Katu Rasa and Deepana property, Virechana, Snehapana and Vasti. These procedures help in Amapachana, Vatashamana, and Strotoshodhana and have lesser side effects. Present case study was done on the female patient of Amavata in which the successful withdrawal of the DMARDs and NSAIDs were done with the help of Ayurvedic medicine